EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies

Rupesh V Chikhale, Surbhi Pravin Pawar, Mahima Sudhir Kolpe, Omkar Dilip Shinde, Kholood A Dahlous, Saikh Mohammad, Pritee Chunarkar Patil, Shovonlal Bhowmick

Molecular Diversity · 2024

DOI: 10.1007/s11030-024-10967-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2024. Verfasst von Rupesh V Chikhale und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, London, UK. R.Chikhale@ucl.ac.uk. Hauptthemen laut MEDLINE: Nucleoside-Phosphate Kinase, Molecular Docking Simulation, Molecular Dynamics Simulation, Machine Learning. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thymidylate kinase (TMK) is a pivotal enzyme in Mycobacterium tuberculosis (Mtb), crucial for phosphorylating thymidine monophosphate (dTMP) to thymidine diphosphate (dTDP), thereby playing a critical role in DNA biosynthesis. Dysregulation or inhibition of TMK activity disrupts DNA replication and cell division, making it an attractive target for anti-tuberculosis drug development. In this study, the statistically validated pharmacophore mode was developed from a set of known TMK inhibitors. Further, the robust pharmacophore was considered for screening the Enamine database. The chemical space was reduced through multiple molecular docking approaches, pharmacokinetics, and absolute binding energy estimation. Two different molecular docking algorithms favor the strong binding affinity of the proposed molecules towards TMK. Machine learning-based absolute binding energy also showed the potentiality of the proposed molecules. The binding interactions analysis exposed the strong binding affinity between the proposed molecules and active site amino residues of TMK. Several statistical parameters from all atoms MD simulation explained the stability between proposed molecules and TMK in the dynamic states. The MM-GBSA approach also found a strong binding affinity for each proposed molecule. Therefore, the proposed molecules might be crucial TMK inhibitors for managing Mtb inhibition subjected to in vitro/in vivo validations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleoside-Phosphate KinaseMolecular Docking SimulationMolecular Dynamics SimulationMachine LearningMycobacterium tuberculosisAntitubercular AgentsEnzyme InhibitorsProtein Kinase InhibitorsProtein BindingPharmacophore

Stichwörter der Autor:innen

Machine learningMolecular dockingMolecular dynamicsMycobacterium tuberculosisPharmacophoreThymidylate kinaseVirtual screening

Substanzen

Nucleoside-Phosphate KinasedTMP kinaseAntitubercular AgentsEnzyme InhibitorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, London, UK. R.Chikhale@ucl.ac.uk.
  • SilicoScientia Private Limited, Nagananda Commercial Complex, No. 07/3, 15/1, 18th Main Road, Jayanagar 9th Block, Bengaluru, 560041, India.
  • Department of Bioinformatics, Rajiv Gandhi Institute of IT and Biotechnology, Bharati Vidyapeeth (Deemed to be University), Pune-Satara Road, Pune, India.
  • Department of Chemistry, College of Science, King Saud University, 11451, Riyadh, Saudi Arabia.

Zitieren

APA

Chikhale, R. V., Pawar, S. P., Kolpe, M. S., Shinde, O. D., Dahlous, K. A., Mohammad, S., Patil, P. C., & Bhowmick, S. (2024). Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies. Molecular Diversity. https://doi.org/10.1007/s11030-024-10967-w

Vancouver

Chikhale RV, Pawar SP, Kolpe MS, Shinde OD, Dahlous KA, Mohammad S, et al. Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies. Molecular Diversity. 2024. doi:10.1007/s11030-024-10967-w

BibTeX
@article{Chikhale2024,
  author = {Chikhale, Rupesh V and Pawar, Surbhi Pravin and Kolpe, Mahima Sudhir and Shinde, Omkar Dilip and Dahlous, Kholood A and Mohammad, Saikh and Patil, Pritee Chunarkar and Bhowmick, Shovonlal},
  title = {Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies},
  journal = {Molecular Diversity},
  year = {2024},
  doi = {10.1007/s11030-024-10967-w}
}
Kostenlos starten →